You are here: Industry Insights > seizure

News List

Ontozry Receives Positive CHMP Opinion Treatment of Uncontrolled Focal Onset Seizures americanpharmaceuticalreview
February 04, 2021
Arvelle Therapeutics announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of cenobamate for the adjunctive treatment of focal onset seizures with or without secondary ...
Glenmark Pharma receives US FDA nod for seizure treatment drug expresspharma
February 04, 2021
Glenmark Pharmaceuticals said Qudexy extended-release capsules market achieved annual sales of approximately US $120 mn.
FDA Approves Valtoco (diazepam nasal spray) as a Seizure Rescue Treatment drugs
January 14, 2020
Neurelis, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Valtoco (diazepam nasal spray) as an acute treatment of intermittent, stereotypic episodes of frequent seizure activity (ie, seizure clusters, acute repetitive seizure
Old drug offers new hope for children with devastating disorder worldpharmanews
December 20, 2019
A drug that once helped obese adults lose weight, but was withdrawn from the market due to heart risks, may be safe and effective for children with a life-threatening seizure disorder called ...
Eton Receives NDA Acceptance for Oral Liquid Seizure Medication contractpharma
August 30, 2019
ET-105 addresses unmet needs of patients with dysphagia and pediatric patients requiring doses lower than available tablet strengths.
FDA Clears Nayzilam as First Nasal Spray to Treat Seizure Clusters drugs
June 03, 2019
FDA Clears Nayzilam as First Nasal Spray to Treat Seizure Clusters.
FDA Approves Nayzilam (midazolam) Nasal Spray to Treat Seizure Clusters drugs
May 21, 2019
FDA Approves Nayzilam (midazolam) Nasal Spray to Treat Seizure Clusters.
Tool Predicts Seizure Risk During, After Pregnancy drugs
May 15, 2019
A prognostic model can predict the risk for seizures in pregnant women with epilepsy on medication, according to a study published online May 13 in PLOS Medicine.
Lupin launches generic seizure drug in US expressbpd
May 13, 2019
The company has launched Clobazam tablets in the strengths of 10 mg and 20 mg, after having received an approval from the United States Food and Drug Administration
FDA refuses Zogenix’s seizure drug Fintepla pharmatimes
April 11, 2019
The U.S. Food and Drug Administration (FDA) has refused to fully review Zogenix’s marketing application for its seizure drug, Fintepla (ZX008, low-dose fenfluramine).

Previous page 1 2 Next page